salicylsalicylic acid has been researched along with Hypertension in 2 studies
salicylsalicylic acid: structure
salsalate : A dimeric benzoate ester obtained by intermolecular condensation between the carboxy of one molecule of salicylic acid with the phenol group of a second. It is a prodrug for salycylic acid that is used for treatment of rheumatoid arthritis and osteoarthritis and also shows activity against type II diabetes.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Salsalate regulated inflammation by affecting the expression of genes from MAPK signalling and NOD-like receptor signalling pathways and lipid metabolism by affecting hepatic expression of genes that favour lipid oxidation from PPAR-α signalling pathways." | 1.46 | Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls. ( Haluzík, M; Kazdová, L; Kuda, O; Landa, V; Mlejnek, P; Oliyarnyk, O; Pravenec, M; Šilhavý, J; Šimáková, M; Škop, V; Strnad, H; Trnovská, J; Zídek, V, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trnovská, J | 1 |
| Šilhavý, J | 1 |
| Kuda, O | 1 |
| Landa, V | 1 |
| Zídek, V | 1 |
| Mlejnek, P | 1 |
| Šimáková, M | 1 |
| Strnad, H | 1 |
| Škop, V | 1 |
| Oliyarnyk, O | 1 |
| Kazdová, L | 1 |
| Haluzík, M | 1 |
| Pravenec, M | 1 |
| Phillips, BB | 1 |
| Joss, JD | 1 |
| Mulhausen, PL | 1 |
2 other studies available for salicylsalicylic acid and Hypertension
| Article | Year |
|---|---|
Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls.
Topics: Adipose Tissue, Brown; Animals; Animals, Genetically Modified; C-Reactive Protein; Fatty Acids, None | 2017 |
Blood pressure elevation in a patient treated with salsalate.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Humans; Hypertension; Low Back Pain; Male; Salicylate | 2002 |